Literature DB >> 34395307

The Growth Kinetics of Collision Nodal Metastasis from Medullary and Papillary Thyroid Carcinomas: A Case Report.

Hao Li1,2, Nir Livneh1,3, Snjezana Dogan4, Ashok R Shaha1.   

Abstract

INTRODUCTION: The collision of medullary (MTC) and papillary thyroid carcinoma (PTC) in the same cervical lymph node can occur, but its growth kinetics has not been reported. CASE
PRESENTATION: We report a 27-year-old male patient who had collision nodal metastases from PTC and sporadic MTC in the central compartment. This was treated with total thyroidectomy and central neck dissection. The collision nodal metastasis persisted and presented with a single sonographically enlarging central compartmental lymph node postoperatively. The volume of the collision nodal metastasis increased from 226 to 507 mm3 over the first 8 months, from 507 to 572 mm3 over the next 6 months, and from 572 to 762 mm3 over the next 31 months. The calcitonin and carcinoembryonic antigen (CEA) fluctuated in the first 19 months followed by a steady increase at a doubling time of 1.97 and 8.42 years, respectively. Unstimulated thyroglobulin remained at 0.2 ng/mL or lower during the same period while thyrotropin (TSH) was not suppressed. Revision central neck dissection performed 4.5 years later resulted in undetectable serum calcitonin, CEA of 2 ng/mL, and thyroglobulin of 0.1 ng/mL from a preoperative calcitonin of 212 ng/L, CEA of 10 ng/mL, and thyroglobulin of 0.2 ng/mL. Further structural imaging 13.5 months later revealed no evidence of disease. DISCUSSION: The growth kinetics of collision nodal metastasis from PTC and MTC can be similar to conventional PTC and MTC. Furthermore, the growth rate of such collision nodal metastases can be slow. Guided by tumor marker doubling time and regular structural imaging, surgical salvage performed after a period of active surveillance may still result in biochemical and structural remission.
Copyright © 2020 by European Thyroid Association Published by S. Karger AG, Basel.

Entities:  

Keywords:  Collision nodal metastasis; Growth kinetics; Medullary thyroid carcinoma; Papillary thyroid carcinoma

Year:  2020        PMID: 34395307      PMCID: PMC8314775          DOI: 10.1159/000511184

Source DB:  PubMed          Journal:  Eur Thyroid J        ISSN: 2235-0640


  22 in total

1.  Thyroid carcinomas involving follicular and parafollicular C cells: seventeen cases with characterization of RET oncogenic activation.

Authors:  M-C Vantyghem; P Pigny; E Leteurtre; L Leclerc; C Bauters; C Douillard; M D'Herbomez; B Carnaille; C Proye; J-L Wemeau; M Lecomte-Houcke
Journal:  Thyroid       Date:  2004-10       Impact factor: 6.568

2.  Concurrent papillary and medullary thyroid carcinoma.

Authors:  Marlo M Nicolas; Antonio Galvao Neto; Mario A Luna
Journal:  Arch Pathol Lab Med       Date:  2005-02       Impact factor: 5.534

Review 3.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

4.  Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy.

Authors:  Akira Miyauchi; Takumi Kudo; Akihiro Miya; Kaoru Kobayashi; Yasuhiro Ito; Yuuki Takamura; Takuya Higashiyama; Mitsuhiro Fukushima; Minoru Kihara; Hiroyuki Inoue; Chisato Tomoda; Tomonori Yabuta; Hiroo Masuoka
Journal:  Thyroid       Date:  2011-06-07       Impact factor: 6.568

5.  Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years.

Authors:  Reese W Randle; Courtney J Balentine; Glen E Leverson; Jeffrey A Havlena; Rebecca S Sippel; David F Schneider; Susan C Pitt
Journal:  Surgery       Date:  2016-11-11       Impact factor: 3.982

6.  Suspicious cervical lymph nodes detected after thyroidectomy for papillary thyroid cancer usually remain stable over years in properly selected patients.

Authors:  E Robenshtok; S Fish; A Bach; Jose M Domínguez; A Shaha; R M Tuttle
Journal:  J Clin Endocrinol Metab       Date:  2012-05-25       Impact factor: 5.958

Review 7.  Collision tumors of the thyroid: A case report and review of the literature.

Authors:  Neil Ryan; Graham Walkden; Darko Lazic; Paul Tierney
Journal:  Head Neck       Date:  2015-06-30       Impact factor: 3.147

8.  Composite metastatic carcinoma in lymph nodes of patients with concurrent medullary and papillary thyroid carcinoma: a report of two cases.

Authors:  Tomohisa Seki; Kaori Kameyama; Hiroshi Hayashi; Mitsuji Nagahama; Katsuhiko Masudo; Nobuhiro Fukunari; Kumi Tanaka; Kiminori Sugino; Koichi Ito; Hiroshi Takami
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

9.  Concurrent papillary and medullary thyroid carcinomas with mixed metastases to lymph nodes.

Authors:  Abdul-Wahed N Meshikhes; Mukund Tingura; Jamal Y Al-Saeed
Journal:  Saudi Med J       Date:  2004-03       Impact factor: 1.484

10.  Mixed medullary - papillary carcinoma thyroid: an uncommon variant of thyroid carcinoma.

Authors:  Manjula Jain; Deepti Verma; Shaji Thomas; Richa Chauhan
Journal:  J Lab Physicians       Date:  2014-07
View more
  1 in total

1.  Thyroid cancer in the era of endocrine disrupting compounds.

Authors:  Cristina Preda
Journal:  Arch Clin Cases       Date:  2021-12-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.